Dr. Bernicker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2030 Mountain View Ave
Ste 540
Longmont, CO 80501Phone+1 720-494-7110Fax+1 720-494-7111
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1994 - 1997
- Baylor College of MedicineResidency, Internal Medicine, 1991 - 1993
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1990 - 1991
- Baylor College of MedicineClass of 1990
Certifications & Licensure
- CO State Medical License 2023 - 2025
- TX State Medical License 1991 - 2024
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
- Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy Start of enrollment: 2021 Oct 14
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 91 citationsOsimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS)Kartik Anand, Joe Ensor, Barry H. Trachtenberg, Eric H. Bernicker
JACC. Cardiooncology. 2019-12-01 - 22 citationsDisparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st CenturyShraddha M. Dalwadi, Gary D. Lewis, Eric H. Bernicker, E. Brian Butler, Bin S. Teh
Clinical Lung Cancer. 2019-05-01 - 19 citationsUpdate on emerging biomarkers in lung cancer.Eric H. Bernicker, Timothy Craig Allen, Phillip T. Cagle
Journal of Thoracic Disease. 2019-01-01
Authored Content
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase InhibitorsJanuary 2018
Press Mentions
- Air Pollution – Second Leading Cause of Lung CancerSeptember 13th, 2021
- A Delicate Dance: Immunocompromised Houstonians Turn to Virtual Boot-Scooting to Stay ConnectedApril 14th, 2020
- Vaping Isn't Just Dangerous, It's LethalNovember 13th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: